The decision brought an end to an unusually fierce campaign — fought in private and public — by Paris-based rival PAI Partners, which refused to accept it had lost and tried to upend the transaction, ...

After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its ...

The decision brought an end to an unusually fierce campaign — fought in private and public — by Paris-based rival PAI ...

Advent International, Blackstone Inc., Groupe Bruxelles Lambert NV and PAI Partners have also proceeded into the next round ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Earlier this month, Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

With this fundraise, the company is seeking to shore up domestic shareholding with “well-known and credible” names ...

Plus, James Gorman gets a promotion at Disney and how Jeff Yass turned gambling wins into a colossal trading giant ...

Family offices of Manipal group chief Ranjan Pai, Mankind Pharma brothers Ramesh Juneja and Rajeev Juneja, and Cipla are ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...